Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.958,28
0,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Viracta Therapeutics Inc (VIRX) Viracta Therapeutics Inc (VIRX) Notizie

Viracta Therapeutics Inc

VIRX
0,8102
-0,0298 (-3,55%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/4/202414:00GLOBEViracta Therapeutics Announces Positive Topline Nana-val..
01/4/202414:30GLOBEViracta Therapeutics to Present Topline Nana-val Results..
07/3/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:12EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEViracta Therapeutics Reports Fourth Quarter and Full Year..
29/2/202414:00GLOBEViracta Therapeutics Announces Completion of Second-Stage..
28/2/202402:40EDGAR2Form 144 - Report of proposed sale of securities
28/2/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202422:05GLOBEViracta Therapeutics to Present at the Oppenheimer 34th..
04/1/202414:00GLOBEViracta Therapeutics Provides Clinical Update and Outlook..
12/12/202314:00GLOBEViracta Therapeutics Announces Orphan Drug Designation..
04/12/202322:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:30GLOBEViracta Therapeutics Announces Interim Data from Phase 1b/2..
29/11/202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:30EDGAR2Form 8-K - Current report
09/11/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:30EDGAR2Form 8-K - Current report
09/11/202314:30GLOBEViracta Therapeutics Reports Third Quarter 2023 Financial..
07/11/202322:15GLOBEViracta Therapeutics to Present at Upcoming Investor..
04/10/202313:01EDGAR2Form 8-K - Current report
04/10/202313:00GLOBEViracta Therapeutics to Host R&D Day Highlighting Nana-val..
05/9/202315:00GLOBEViracta Therapeutics to Host R&D Day on October 4, 2023
30/8/202300:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202300:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:05GLOBEViracta Therapeutics Announces New Employment Inducement..
16/8/202323:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202322:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:02EDGAR2Form 8-K - Current report
14/8/202314:00GLOBEViracta Therapeutics Reports Second Quarter 2023 Financial..
08/8/202314:30GLOBEViracta Therapeutics Announces Publication in Blood Advances..
07/8/202313:36EDGAR2Form 8-K - Current report
07/8/202313:30GLOBEViracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D...
28/6/202314:00GLOBEViracta Therapeutics’ Pivotal NAVAL-1 Trial Achieves..
31/5/202322:15GLOBEViracta Therapeutics to Present at the Jefferies Healthcare..
11/5/202322:05GLOBEViracta Therapeutics to Present at the RBC Capital Markets..
08/5/202322:05GLOBEViracta Therapeutics Reports First Quarter 2023 Financial..
Apertura: 0,8212 Min: 0,80 Max: 0,84
Chiusura: 0,84

La tua Cronologia

NASDAQ
VIRX
Viracta Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network